Baxter International Inc. (BAX): Price and Financial Metrics


Baxter International Inc. (BAX)

Today's Latest Price: $81.09 USD

0.36 (-0.44%)

Updated Oct 23 7:00pm

Add BAX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

BAX Stock Summary

  • Baxter International Inc's market capitalization of $41,379,381,774 is ahead of 95.16% of US-listed equities.
  • BAX's went public 34.83 years ago, making it older than 92.9% of listed US stocks we're tracking.
  • In terms of volatility of its share price, BAX is more volatile than only 0.61% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Baxter International Inc are A, RMD, EBAY, ETN, and PHG.
  • Visit BAX's SEC page to see the company's official filings. To visit the company's web site, go to www.baxter.com.

BAX Stock Price Chart Interactive Chart >

Price chart for BAX

BAX Price/Volume Stats

Current price $81.09 52-week high $95.19
Prev. close $81.45 52-week low $69.10
Day low $80.84 Volume 1,676,967
Day high $81.93 Avg. volume 3,088,427
50-day MA $81.86 Dividend yield 1.2%
200-day MA $85.37 Market Cap 41.05B

Baxter International Inc. (BAX) Company Bio


Baxter International provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The company was founded in 1931 and is based in Deerfield, Illinois.

BAX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$81.09$26.42 -68%

We started the process of determining a valid price forecast for Baxter International Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Baxter International Inc ranked in the 22th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Baxter International Inc, consider:

  • BAX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 29.2% of tickers in our DCF set.
  • Baxter International Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 8. This value is greater than only 21.45% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-68%
1%-68%
2%-68%
3%-67%
4%-67%
5%-67%

Want more companies with a valuation profile/forecast similar to that of Baxter International Inc? See ABT, GMED, MDT, OFIX, and SRDX.


BAX Latest News Stream


Event/Time News Detail
Loading, please wait...

BAX Latest Social Stream


Loading social stream, please wait...

View Full BAX Social Stream

Latest BAX News From Around the Web

Below are the latest news stories about Baxter International Inc that investors may wish to consider to help them evaluate BAX as an investment opportunity.

Catheter Securement Devices Market Insights, Forecast to 2027 | 3M Company, C.R. Bard, Baxter International, Convatec Inc, etc.

Industry Overview of Catheter Securement Devices Market Report 2020 The global catheter securement devices market is forecast to reach USD 1.74 Billion by 2027, according to a new report by Reports and Data. Catheter Securement Devices can be defined as medical

OpenPR | October 1, 2020

Acute Wound Care Market With Leading Players like Molnlycke Health Care AB, Smith & Nephew plc., Acelity L.P. Inc., ConvaTec Group Plc., 3M, Ethicon, Medtronic, Coloplast A/S, Hollister Incorporated, Baxter International Inc.

Acute wounds affect millions of people each day worldwide. In the recent decades, clinicians have gained a better understanding of the mechanisms underlying wound repair and healing. Acute wound care management involves number of products that are used by physicians

OpenPR | September 29, 2020

Peritoneal Dialysis Market - Global Outlook & Forecast Report 2020-2025 Featuring Baxter International, Fresenius Medical Care, Medionics, Medtronic

DUBLIN, Sept. 28, 2020 /PRNewswire/ -- The "Peritoneal Dialysis Market - Global Outlook & Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The peritoneal dialysis market by revenue is expected to grow at a CAGR of over 6% during the period 2019-2025 Market…

PR Newswire | September 28, 2020

United States Medical Syringes Procurement Research Report 2020 Featuring Cardinal Health, Becton, Dickinson and Co, 3M Company, Fresenius Group & Baxter International - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Syringes in the US - Procurement Research Report" has been added to ResearchAndMarkets.com's offering. This report is intended to assist buyers of disposable syringes used for medical purposes There are different types of medical syringes, including hypodermic syringes, medical bulb syringes, blood collection syringes and fountain syringes. This report includes prefilled syringes, which are disposable syringes prefilled with unit dose medication. Although t

Business Wire | September 25, 2020

Baxter Announces Exclusive Distribution Agreement With bioMérieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced a distribution agreement with bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, for the NEPHROCLEARTM CCL14 diagnostic test. The NEPHROCLEARTM CCL14 test is currently in development for use in assessing the risk of developing persistent severe acute kidney injury (AKI). The agreement is part of a previously announced collaboration between Baxter and bioMérieux to i

Business Wire | September 16, 2020

Read More 'BAX' Stories Here

BAX Price Returns

1-mo 3.04%
3-mo -8.89%
6-mo -12.01%
1-year 6.07%
3-year 29.99%
5-year 138.35%
YTD -2.24%
2019 28.40%
2018 2.89%
2017 47.30%
2016 17.58%
2015 -2.13%

BAX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BAX Dividend History

Continue Researching BAX

Want to see what other sources are saying about Baxter International Inc's financials and stock price? Try the links below:

Baxter International Inc (BAX) Stock Price | Nasdaq
Baxter International Inc (BAX) Stock Quote, History and News - Yahoo Finance
Baxter International Inc (BAX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8733 seconds.